Top compounds associated with response to RWDD4


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.04
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.076 0.04
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.068 0.04
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.086 0.04
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.07 0.04
mRNA RO4929097 CTRPv2 pan-cancer AAC -0.11 0.04
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.065 0.04
mRNA AZD4547 CTRPv2 pan-cancer AAC 0.077 0.04
mRNA CBB-1007 CTRPv2 pan-cancer AAC -0.11 0.05
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.072 0.05
Download CSV